- Home
- TCBP vs ATNF Comparison
TCBP vs ATNF Comparison
Compare TCBP & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- ATNF
- Stock Information
- Founded
- TCBP 2013
- ATNF 2016
- Country
- TCBP United Kingdom
- ATNF United States
- Employees
- TCBP N/A
- ATNF N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- TCBP Health Care
- ATNF Health Care
- Exchange
- TCBP Nasdaq
- ATNF Nasdaq
- Market Cap
- TCBP 3.0M
- ATNF 2.6M
- IPO Year
- TCBP 2022
- ATNF N/A
- Fundamental
- Price
- TCBP $0.65
- ATNF $1.74
- Analyst Decision
- TCBP Strong Buy
- ATNF
- Analyst Count
- TCBP 1
- ATNF 0
- Target Price
- TCBP $3.00
- ATNF N/A
- AVG Volume (30 Days)
- TCBP 1.8M
- ATNF 128.8K
- Earning Date
- TCBP 02-09-2025
- ATNF 02-13-2025
- Dividend Yield
- TCBP N/A
- ATNF N/A
- EPS Growth
- TCBP N/A
- ATNF N/A
- EPS
- TCBP N/A
- ATNF N/A
- Revenue
- TCBP N/A
- ATNF N/A
- Revenue This Year
- TCBP N/A
- ATNF N/A
- Revenue Next Year
- TCBP N/A
- ATNF $54.15
- P/E Ratio
- TCBP N/A
- ATNF N/A
- Revenue Growth
- TCBP N/A
- ATNF N/A
- 52 Week Low
- TCBP $0.44
- ATNF $1.16
- 52 Week High
- TCBP $41.50
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- TCBP 36.84
- ATNF 32.45
- Support Level
- TCBP $0.45
- ATNF $1.69
- Resistance Level
- TCBP $0.70
- ATNF $2.26
- Average True Range (ATR)
- TCBP 0.08
- ATNF 0.19
- MACD
- TCBP 0.10
- ATNF -0.02
- Stochastic Oscillator
- TCBP 55.58
- ATNF 4.61
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.